AT&T sells 7% stake in Tech Mahindra for Rs 660 crore

Submitted by Sunil Kashyap on Thu, 04/29/2010 - 19:24
AT&T sells 7% stake in Tech Mahindra for Rs 660 crore

The largest phone company in the US, AT&T Inc has sold its 7% stake in Tech Mahindra Ltd. Tech Mahindra Ltd. is now controlling the Satyam Computer Services as well. Last month, there was an option of 8% buy of the stake provided by the company.

So far as financial aspects of the deal are concerned, the US Inc. AT&T has raised Rs 660 crore ($147 million) selling its shares in Tech Mahindra Ltd. Rs 762.4 a piece was the price for the sale. As per sources, Citigroup Inc. has advised AT&T on the stock sale.

According to the company's initial share sale document in 2006, AT&T had the option to buy about 9.9 million shares before 31st of July. As per Tech Mahindra, the Dallas, Texas- based company has purchased 9.87 million of shares in an off-market transaction. Moreover, it has paid around Rs 898 crore for the stake.

Mahindra and Mahindra is having a 44% stake in Tech Mahindra where as the British telecommunications company BT has 38% stake in the company.


Tagged with

Miscellaneous

Finance Ministry agrees to dole out Rs 1L crore towards fuel subsidy

Finance Ministry agrees to dole out Rs 1L crore towards fuel subsidy

The Finance Ministry has agreed to pay a record Rs 100,000 crore to state-run oil marketing companies towards diesel and cooking fuel subsidy in 2012-13 to help them avoid the impact of the proposed implementation of Export Parity Price (EPP) pricing formula.

The Finance Ministry wants the pricing model to be changed to EPP, but Indian Oil Corporation Ltd (IOCL), Bharat Petroleum Corporation Ltd (BPCL) and Hindustan Petroleum Corporation Ltd (HPCL) are opposing the proposed change as the new model would bring their profitability down to nearly zero.

Ranbaxy episode to hit Indian drug makers’ ability to win new contracts

Ranbaxy episode to hit Indian drug makers’ ability to win new contracts

Ranbaxy might have cross the hurdle of allegations of supplying poor-quality drugs but the episode will hit the Ranbaxy as well as other Indian pharmaceutical firms' businesses in the future, market analysts believe.

Ranbaxy, which is now owned by Diiachi Sankyo of Japan, pleaded guilty to criminal charges of adopting poor manufacturing practices and supplying certain adulterated drugs produced at its two Indian facilities. The company hit a settlement by agreeing to pay $500 millon in civil damages and fines.

© Copyright 2013